|Bid||206.34 x 1000|
|Ask||220.20 x 800|
|Day's Range||203.50 - 206.46|
|52 Week Range||144.75 - 223.45|
|Beta (3Y Monthly)||0.80|
|PE Ratio (TTM)||22.85|
|Earnings Date||Jan 27, 2020 - Jan 31, 2020|
|Forward Dividend & Yield||2.08 (1.02%)|
|1y Target Est||234.58|
Sustained sales growth is one of the most important characteristics of potential winners in the stock market. It provides investors an insight into product demand and pricing power.
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Moody's Investors Service ("Moody's") placed the Baa1 senior unsecured ratings of Stryker Corporation ("Stryker") under review for downgrade. At the same time, Moody's affirmed the company's Prime-2 commercial paper rating.
Stryker announced a $4 billion plan to acquire Wright Medical Group on Monday — sending the two medical technology stocks on a divergent path by the close of the stock market.
The 2015 Tornier deal — worth more than $3 billion — shifted Wright Medical’s global corporate headquarters to Amsterdam. And now, Wright’s Memphis operations will report to Kalamazoo, Michigan.
NEW YORK, Nov. 04, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Wright Medical Group N.V. (“Wright”.
Stryker, which sells a broad range of medical devices, said Wright’s expertise in devices for the upper extremities would complement Stryker’s product line.
Benzinga Pro's Stocks To Watch For Monday McDonald's (MCD) - Shares were down nearly 2% following news CEO Steve Easterbrook was removed from the company. The company Board deemed Easterbrook in violation ...
US medical device maker Stryker will buy smaller rival Wright Medical in a deal worth $5.4bn including debt as it seeks to boost its exposure to the fast-growing orthopaedics market. Michigan-headquartered Stryker said on Monday that it would pay $30.75 per share for Wright Medical, a near 40 per cent premium to Friday’s closing share price. Shares in Wright Medical soared 31 per cent to $28.78, while Stryker stock fell 2.9 per cent to $212.77 in pre-market trading in New York.
Medical device maker Stryker Corp said on Monday it would buy smaller rival Wright Medical Group for about $4 billion in cash, expanding into the fast-growing business of implants for shoulders and wrists. Latest in a series of consolidations in the medical device industry, the deal will catapult Stryker to become one of the market leaders in implants for the treatment of bone fractures as well joint replacements. The 69-year-old Wright Medical, which recorded sales of $836 million last year, also makes implants for foot and ankle.
Shares of Wright Medical Group N.V. rocketed 32% toward a 3-month high in premarket trading Monday, after the medical device company announced an agreement to be bought out by Stryker Corp. in a deal valued at $5.4 billion, including debt. Styker's stock edged up 0.1%. Under terms of the deal, Stryker will pay $30.75 in cash for each Wright Medical share outstanding, representing a 40% premium to Friday's closing price of $22.01, and valuing Wright Medical at a market capitalization of $3.90 billion. The deal, which is expected to close in the second half of 2020, is not expected to impact adjusted earnings per share next year, and should reduced adjusted EPS by 10 cents in 2021 and add to EPS thereafter. Wright Medical's stock has tumbled 24.3% over the past three months and Styker shares have gained 0.5%, while the S&P 500 has tacked on 4.6%.
Wright Medical Group N.V. (WMGI) today announced that it has entered into a definitive agreement under which Stryker (SYK) will acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for a total equity value of approximately $4.7 billion, including the value of Wright’s outstanding convertible notes, and total enterprise value of approximately $5.4 billion. Under the terms of the agreement, Stryker will commence a tender offer for all outstanding ordinary shares of Wright for $30.75 per share, in cash. The boards of directors of both Stryker and Wright have approved the transaction.
Stryker's $5.4 billion deal for Wright Medical comes as the big medical device maker looks to expand its offerings for upper joint implants, while strengthening its portfolio of implants for lower body joints.
Stryker (SYK) delivered earnings and revenue surprises of 0.00% and 0.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Stryker stock slipped a small fraction late Tuesday after Stryker earnings of $1.91 per share on $3.59 billion in sales narrowly topped analysts' expectations for the third quarter.
Kalamazoo, Michigan, Oct. 29, 2019 -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2019: Third Quarter Highlights Reported net.
The S&P; 500 marked an all-time high while the Dow Jones Industrial Average edged closer to a new record, as health care stocks rallied but techs lagged.